EGFR mutant-specific antibodies directed toward the exon 21 L858R EGFR mutation and exon 19 E746-750 deletions represent an effective screening test for predicting lung cancer response to EGFR-tyrosine kinase inhibitors chemotherapy.
Intestinal Metaplasia Within Squamo-Oxyntic Gap Is Risk Indicator
The Histologic Squamo-Oxyntic Gap: An Accurate and Reproducible Diagnostic Marker of Gastroesophageal Reflux Disease.
Chandrasoma P, Wijetunge S, et al:
Am J Surg Pathol 2010; 34 (November): [1574] [1575] [1576] [1577] [1578] [1579] [1580] [1581] A histologic definition of gastroesophageal reflux disease may include the presence of any metaplastic epithelium between the squamous esophagus and gastric oxyntic-type epithelium.
Background/Objective: Gastroesophageal reflux disorder (GERD) is common and is defined as the condition that develops when there is a reflux of stomach contents that causes troublesome symptoms or complications. While this definition is somewhat intuitive, it is also independent of any histologic or endoscopic findings. Associated with reflux is columnar metaplasia and dysplasia of the esophageal squamous epithelium and the eventual progression to adenocarcinoma. Frequently (up to 40% of the time), patients with GERD do not develop symptoms until they present with adenocarcinoma. Here, the authors argue for a definition of GERD that includes the presence of the gastric cardia.
Methods: All patients seen in a specialized clinic over a 5-year period who had endoscopy with systematic gastric and esophageal biopsies were reviewed by a single pathologist. Epithelial type was described as stratified squamous, cardiac with intestinal metaplasia, cardiac (mucinous cells only), oxyntocardiac (mixture of parietal and mucinous cells below the foveolar region), and gastric oxyntic (no mucinous cells below the foveolar region). The gap between squamous and gastric oxyntic-type mucosa was measured.
Results: 1655 patients met the selection criteria. The length of the squamo-oxyntic gap varied from <1 cm to >10 cm. The presence of intestinal metaplasia was correlated with the overall length of the gap and was present in nearly 90% of patients who had a gap >1 cm. With patients who had intestinal metaplasia throughout the entirety of the squamo-oxyntic gaps, goblet cells were more numerous in the more proximal biopsies. A slight majority of patients had both cardiac and oxyntocardiac-type mucosa within the gap, and nearly one-third also had intestinal metaplasia. Cardiac-type mucosa was more common in patients who had longer squamo-oxyntic gaps. The degree of chronic inflammation varied but was most significant in the cardiac-type mucosa. Five percent of patients had Helicobacter pylori infection identified in their gastric biopsies. For unclear reasons, the follicle-stimulating hormone receptor appears to be widely expressed by tumor endothelial cells within a wide spectrum of human malignancies.
Interesting Article on Follicle-Stimulating Hormone Receptor Expression
Background: Sertoli cells of the testis and granulosa cells of the ovary are the only human tissues that normally express the follicle-stimulating hormone (FSH) receptor. Previous studies have reported expression of the FSH receptor within prostate cancer tumor cells, but no prior reports have documented the pattern of staining within the tumor vasculature.
Objective: To assess the expression of the FSH receptor in tumor endothelial cells among various human malignancies.
Methods: Tissue samples, from 1336 patients, were collected immediately after surgery from malignant tumors of the prostate, breast, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovary. Tumor tissue was frozen and routinely processed using formalin fixation and paraffin embedding. Histologic analysis of each tumor was performed by 5 study investigators, who diagnosed each case and assigned tumor grades using either World Health Organization or American Joint Committee on Cancer guidelines. Control tissue consisted of grossly and microscopically normal tissue obtained from the surgery specimens. Four different antibodies, all of which were monospecific for the FSH receptor, were applied to each sample (FSHR18, FSHR323, FSHR190, and FSHR225). In situ hybridization, confocal microscopy, and immunoblotting procedures were also performed. Finally, immunoelectron microscopy was performed on previously created prostate cancer tumor xenografts in nude mice after the mice were injected with anti-FSH antibodies coupled to colloidal gold.
Results:
The FSH receptor was expressed by endothelial cells in all 1336 tumors, regardless of tumor grade. Expression occurred within vessels at the tumor periphery, in a 10-mm thick zone that included vessels within and just outside the tumor. In normal tissue >10 mm from neoplastic tissue, however, no FSH receptor expression was detected. Tumor lymphatics failed to show any evidence of FSH receptor expression. Immunoelectron microscopic analysis of prostate cancer tissue from mouse xenografts confirmed the presence of the FSH receptor within the endothelial cell luminal surfaces as well as coated vesicles, endosomes, and multivesicular bodies.
Conclusions:
The FSH receptor is widely expressed by tumor-associated endothelial cells within a wide spectrum of human malignancies.
Reviewer's Comments: These findings are interesting, although the reason why the FSH receptor is predominantly expressed in vessels at the tumor periphery and in apparently normal vessels near the tumor periphery is unclear. p16 immunocytochemistry is equally sensitive to HPV DNA testing with superior specificity for predicting which women with low-grade squamous intraepithelial lesion or atypical squamous cell of undetermined significance harbor a high-grade cervical intraepithelial lesion.
Background: Molecular testing for human papillomavirus (HPV) is well established as the method of choice for stratifying patients with atypical cervical cytology results (atypical squamous cells of undetermined significance (ASC-US) into "repeat cytology" or "colposcopy" management groups. HPV testing is most sensitive for predicting high-grade cervical intraepithelial neoplasia (CIN), albeit at the cost of suboptimal specificity resulting in many negative colposcopic examinations. A growing body of evidence suggests that p16INK4a immunocytochemistry is equally sensitive with superior specificity.
Objective: To correlate immunostaining of liquid-based cervical cytologic samples for protein p16INK4a with HPV testing (Digene High-Risk Hybrid Capture [HC2]) as predictors of biopsy-proven, high-grade cervical intraepithelial neoplasia.
Materials/Methods: 810 liquid-based cervical cytologic samples (ThinPrep test vials) were retrospectively identified in 5 Swiss and Italian pathology laboratories and selected for having a cytologic diagnosis of ASC-US or low-grade squamous intraepithelial lesion (LSIL), sufficient residual liquid sample, and available paraffin tissue blocks from follow-up cervical biopsies taken within 6 months of sampling. Additional cytologic slides were prepared with a T2000 slide processor (Hologic) and stained for p16 using the CINtec Cytology Kit (REF 9521, mtm laboratories). Two interpretive methods were used, each calling a positive result for at least 1 morphologically abnormal p16 immunoreactive cell. HV testing was performed using Digene High-Risk HPV Hybrid Capture (HC2). Results were compared to histopathologic separation into 2 groups, CIN 2 or CIN 3 versus CIN 1 or negative, as the gold standard.
Results: Specimen age ranged from 1 to 36 months. Among 385 cytologic cases of ASCUS, 81 revealed CIN 2/CIN 3 histology and 304 were CIN 1/ negative. Among 425 cytologic cases of LSIL, 141 revealed CIN 2/CIN 3 histology and 284 were CIN 1/negative. p16 immunocytochemistry showed similar sensitivity (92.6% in the ASCUS group and 92.2% in the LSIL group) to HPV testing (90.1% in the ASCUS group and 95.7% in the LSIL group) for predicting histologic evidence for high-grade CIN. p16 immunocytochemistry showed superior specificity (63% to 71% in the ASCUS group and 37% to 53% in the LSIL group) to HPV testing (38% in the ASCUS group and 18% in the LSIL group) for predicting histologic evidence for high-grade CIN.
Conclusions: p16 immunocytochemistry may serve as the first-line triage method for determining management of women with cytology-proven LSIL and may improve upon or replace HPV testing in the management of ASCUS.
Reviewer's Comments:
This study is the first with sufficient statistical power to validate p16 immunocytochemistry as a test method for management of women with LSIL or ASCUS. Test specificity may have been biased/increased by prolonged specimen age or technical preparation of immunocytochemical slides by the study sponsor. Cytotechnologist interpretation of p16 immunocytochemistry was more sensitive, but less specific, than pathologist interpretation in predicting histologic evidence for high-grade CIN. (ReviewerGuy E. Nichols, MD, PhD). Serum hyaluronic acid level is a predictor of the degree of hepatic fibrosis in pediatric patients.
Hyaluronic Acid Level Helps Predict Fibrosis in Children With NAFLD
Background: In children and adolescents, the most common chronic liver disease is nonalcoholic fatty liver disease (NAFLD), which affects up to 80% of obese individuals in this age group. The disease is associated with the development of hepatic fibrosis and may eventually progress to cirrhosis. Recent studies have found that, in adults, serum hyaluronic acid (HA) measurement is a good marker for liver fibrosis.
Objective: To determine the diagnostic utility of serum HA measurement as a marker of hepatic fibrosis in children with NAFLD.
Some Ulcerative Colitis Patients May Have Focal Gastritis or Chronic Duodenitis

Morphologic Findings in Upper Gastrointestinal Biopsies of Patients With Ulcerative Colitis: A Controlled Study.
Lin J, McKenna BJ, Appelman HD:
Am J Surg Pathol 2010; 34 (November): [1672] [1673] [1674] [1675] [1676] [1677] Chronic duodenitis in patients with ulcerative colitis who have undergone colectomy is associated with pouchitis.
Background: Ulcerative colitis is usually thought of as a disease that affects only the mucosa of the rectum and colon. Recently, some have shown that chronic inflammatory lesions of the upper gastrointestinal tract are present with increased frequency in patients with ulcerative colitis compared to control patients.
Objective: To ascertain and describe the types of inflammatory conditions seen in the stomachs, esophagi, and duodenums of patients with ulcerative colitis.
Participants/Methods: 69 patients who had biopsy-confirmed ulcerative colitis and had biopsies of the esophagus, stomach, and/or duodenum and were seen at a single institution were included. Biopsies were compared to those of a control group of patients who did not have ulcerative colitis. All biopsies were taken randomly rather than by protocol. The biopsies were reviewed by 3 pathologists, and all histologic features were recorded.
Results: 16 of the 69 patients were <18 years old. Twenty-four patients had biopsies of the esophagus, 66 of the stomach, and 40 of the duodenum. Ten of the ulcerative colitis patients had undergone complete colectomy. With esophageal biopsies, control patients were more likely to have ulcers; no other changes were significant. With gastric biopsies, ulcerative colitis patients were more likely to have a focal gastritis than were the controls, defined as a localized collection of lymphocytes, neutrophils, and macrophages surrounding at least 1 pit, neck, or gland. This was seen in nearly 30% of the patients with ulcerative colitis. Ulcerative colitis patients were also more likely to have basal mixed inflammation and a superficial plasmacytosis than controls in their gastric biopsies. Control patients were more likely to have Helicobacter pylori gastritis. With duodenal biopsies, patients with ulcerative colitis were more likely to have a diffuse chronic duodenitis characterized by diffuse mucosal chronic inflammation, mainly plasmacytic, with a variable number of neutrophils either within the lamina propria or involving the crypts. Architectural distortion, similar to that seen in the colon with chronic ulcerative colitis, was also present. These changes were present in 10% of the biopsies of ulcerative colitis patients. This duodenitis occurred only in patients who had previously undergone colectomy, and all of these patients had also developed a pouchitis.
Conclusions:
Although most patients who have ulcerative colitis have normal upper gastrointestinal biopsies, some may have a focal gastritis or chronic duodenitis. The chronic duodenitis appears to be closely related to the development of pouchitis.
EMP2 Expression May Be Predictor of Development of Endometrial Ca
Epithelial Membrane Protein-2 Expression Is an Early Predictor of Endometrial Cancer Development.
Habeeb O, Goodglick L, et al: Increased EMP2 expression may predict development of endometrial carcinoma in patients with endometrial hyperplasia.
Background: Endometrial cancer is the most common gynecologic malignancy. The progression from hyperplasia to endometrioid adenocarcinoma has been well studied, but only a fraction of patients with endometrial hyperplasia progress to malignancy. Currently, there is no reliable method to distinguish which patients will progress, so most patients with pre-neoplastic disease undergo conservative management, including hormonal treatment. Epithelial membrane protein 2 (EMP2) is a biomarker that was recently identified as a marker for endometrial carcinoma progression and more aggressive endometrial tumor behavior.
Objective:
To evaluate the expression of EMP2 in a variety of benign and pre-neoplastic endometrial conditions as a potential marker of future endometrioid adenocarcinoma development.
Methods:
A tissue microarray (TMA) was constructed from endometrial biopsies and curettages from women with a variety of benign endometrial conditions (proliferative, secretory, or polyp), pre-neoplastic conditions (simple or complex hyperplasia with or without atypia), and primary endometrial endometrioid adenocarcinoma. Each sample was represented by 3 tissue cores on the TMA. The majority of patients included in the study had follow-up biopsies (metachronous samples) also included in the TMA, of which a subset had disease progression to endometrioid adenocarcinoma. Immunohistochemical staining for EMP2 was performed on the TMA, and the percentage of cells stained was scored.
Results: 207 patients with 535 surgical specimens were included in the TMA. The samples included 231 benign biopsies, 195 pre-neoplastic biopsies, and 109 endometrioid adenocarcinomas; 150 patients had at least 2 specimens, and 46 patients had disease progression to endometrial adenocarcinoma. EMP2 immunohistochemistry showed cytoplasmic and/or membranous staining in 52% of tissue samples. There was a step-wise increase in relative EMP2 expression from benign to pre-neoplastic to endometrioid adenocarcinoma. There was some degree of heterogeneity of EMP2 expression in the pre-neoplastic group; when subgroup analysis was performed, there was a striking increase in EMP2 expression in pre-neoplastic lesions from patients who eventually developed endometrioid adenocarcinoma. However, the EMP2 expression level did not correlate with disease progression in benign biopsies.
What Are Basic Strategies for Optimal PNH Testing?
Guidelines for the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria and Related Disorders by Flow
Cytometry. Granulocyte analysis is more accurate than monocyte and red cell analysis for measuring GPI-deficient cells. Granulocytes identified by light scatter, and CD15 back-gating can be assessed for abnormal decreases in CD24/FLAER staining.
Background: Paroxysmal nocturnal hemoglobinuria (PNH) typically presents with complement-mediated hemolysis and often with life-threatening thrombosis or bone marrow failure. PNH arises from acquired stem cell mutations, leading to deficiency of cell membrane proteins linked to glycophosphatidylinositol (GPI) anchors. PNH is a highly morbid disease that can be treated by the monoclonal antibody eculizumab, making diagnostic testing vital.
Objective: To improve technical, interpretive, and reporting standards for paroxysmal nocturnal hemoglobinuria testing.
Methods: Consensus guidelines were developed at the 2008 Clinical Cytometry Society Meeting.
Recommendations provide novel technical, interpretive, and reporting guidelines to improve the sensitivity, reproducibility, and clinical utility of PNH testing. Recommendations: PNH testing should be considered for patients with unexplained hemoglobinuria, Coombs-negative hemolytic anemia, thrombosis of unusual sites (including hepatic and cerebral vessels), synchronous thrombosis and cytopenias, myelodysplastic syndromes with unilineage dysplasia, and aplastic anemia. PNH testing should be performed on peripheral blood, ideally but not necessarily in EDTA and within 48 hours of collection. Granulocyte and monocyte analysis using a stain-then-lyse protocol is most accurate for measuring GPI-deficient cells. Light scatter and CD15 (bright) back-gating are ideal for granulocyte gating; CD33/CD64 or CD163 is ideal for back-gating for monocytes. Fluorescent aerolysin (FLAER) binds specifically to GPI in a maturation-independent manner and is the best PNH reagent, ideally in combination with CD24 or CD66b for granulocytes and CD14 for monocytes. CD16a is less optimal. CD55 and CD59 are not recommended. Red cell analysis must be performed in cases with leukocyte GPI deficiency and may be performed in all cases, ideally with a stain-then-wash protocol that employs multiple washes and vigorous mechanical disaggregation (vortexing, "racking"). Glycophorin A backgating is used with CD59 staining to distinguish and quantify normal (Type I), partially deficient (Type II), and GPI-deficient (Type III) erythrocytes. Pathologic erythrocytes typically number less than GPI-deficient leukocytes.
Reporting of large PNH clones should include the percentage of GPI-deficient cells for granulocytes, monocytes, and red cells. Small PNH-like populations (<1%) should also be described, especially in myelodysplastic syndrome and aplastic anemia patients, since these indicate a need for follow-up monitoring, regardless of whether they represent truly clonal populations.
Conclusions:
Routine diagnosis and monitoring of PNH can be achieved by careful and deliberate attention to standard clinical flow cytometric practices as outlined in this report.
Reviewer's Comments: Laboratories can apply current guidelines to effectively establish routine, diagnostic assays for clinically significant disease (as low as 1% GPI-deficient cells). High-sensitivity assays (as low as 0.01% GPI-deficient cells) require acquisition of many events (250,000 to 500,000 cells of interest) and substantial laboratory experience with running and interpreting the assay. Monitoring of PNH patients treated with eculizumab will reveal paradoxical post-treatment increases in the fraction of GPI-deficient red cells, since abnormal red cells are now protected from complement-mediated hemolysis. (Reviewer-Guy E. Nichols, MD, PhD).
Should Molecular Diagnostic Labs Adopt Consensus Primer Sets for TCR Gene Rearrangement Testing?
Evaluation of T-Cell Clonality in Archival Skin Biopsy Samples of Cutaneous T-Cell Lymphomas Using the Biomed-2 PCR Protocol.
Lukowsky A, Muche JM, et al: Diagn Mol Pathol 2010; 19 (June): 70-77 European consensus polymerase chain reaction primer sets recommended for standardization of B-and T-cell clonality assays showed similar or worse sensitivity compared to a conventional T-cell receptorgamma assay and slightly lower specificity.
Background:
In 2003, an extensive European collaborative effort developed a standardized multi-plexed PCR primer sets and protocols for optimal evaluation of B-and T-cell clonality (immunoglobulin and T-cell receptor [TCR] gene rearrangement). The goal was to improve and standardize PCR clonality assays as adjunct tests in the diagnosis of lymphoma and leukemia. These primer sets and protocols have been validated in frozen tissue specimens but not in archival paraffin-embedded tissues.
Objective: To apply recently standardized PCR primer sets and protocols (Biomed-2 Concerted Action) to analysis of T-cell clonality in archival formalin-fixed paraffin-embedded skin tissues.
Methods: 107 consecutive formalin-fixed paraffin-embedded skin lesions were retrieved from archives in the Benjamin Franklin, Charité-Universitäsmedizin Berlin pathology department. These lesions included 84 cutaneous T-cell lymphomas, 3 systemic T-cell lymphomas, and 20 controls (5 B-cell lymphomas, 13 benign dermatoses, and 2 pseudolymphomas). Extracted DNA was amplified using 2 TCR-gamma PCR (Biomed sets A and B) and 3 TCR-beta PCR (Biomed sets A, B, C) and was compared to an in-house TCR-gamma assay.
Results: Among 84 paraffin-embedded skin lymphomas, the Biomed TCR-gamma assay demonstrated clonal PCR products in 68 samples (81%) compared to 72 (86%) for the in-house TCR-gamma assay. The more complex Biomed TCR-beta assay was unsuccessful in 4 cases and demonstrated clonal PCR products in 62 of 80 samples (78%). All 3 assays were statistically comparable. Combining the Biomed TCR-beta and -gamma assays increased the sensitivity to 87%. The in-house TCR-gamma assay was 100% specific, but the Biomed TCR-beta and -gamma assays together produced 3 equivocal results in the control set.
Conclusions:
Biomed-2 consensus multi-plexed PCR primer sets and protocols are recommended for standardization of B-and T-cell clonality assays but, in 84 paraffin-embedded cutaneous T-cell lymphomas, showed comparable sensitivity to a conventional TCR-gamma assay with slightly lower specificity.
Reviewer's Comments: These results are not going to compel an established molecular diagnostic lab to exchange its existing TCR-gamma primer sets or protocols. In my experience, specificity is a major concern for T-cell clonality PCR assays. Due to the limited repertoire of TCR-gamma rearrangements, occasional benign reactive oligoclonal T-cell populations can be amplified, producing "pseudoclonal" results, and this risk of falsepositive results increases with limited sample size. Most successful laboratories may prefer their current TCRgamma protocols but may consider adding a TCR-beta assay. (Reviewer-Guy E. Nichols, MD, PhD). Well-differentiated osteosarcomas of the jaw are very rare and have a good prognosis.
Background: Osteosarcoma of the jaw bones is somewhat uncommon. The site accounts for approximately 6% of skeletal osteosarcomas. Most of the tumors arise in the mandible, usually in the third or fourth decade of life. Most tumors are high-grade; lower-grade tumors (such as parosteal osteosarcomas) are very rare. As such, intramedullary osteosarcomas are sometimes mistaken for fibro-osseous lesions, whereas extramedullary tumors can be confused for osteomas.
Objective: To describe a series of well-differentiated gnathic osteosarcomas.
Methods:
The surgical pathology files of a single institution as well as the authors' personal consultation files were searched for all cases of gnathic, grade 1 of 3 osteosarcomas. Histology and radiographs (when available) were reviewed. Clinical information and follow-up were pursued.
Results: There were 15 cases from 8 females and 7 males. More than half the patients were aged >40 years. Nine tumors arose in the maxilla, and 6 were in the mandible. No patient had a history of radiation exposure, and all tumors except 1 were intramedullary. The intraosseous tumors were variable radiolucent and dense and were poorly defined. Tumors eroded through the cortex into the soft tissue with an associated periosteal reaction or expanded the bone without cortical destruction. The tumor that arose on the surface of the bone merged with the underlying bone and had an appearance similar to that of an osteoma. Tumors were white-tan and hard, and sizes ranged from 0.5 to 6 cm. The parosteal osteosarcoma was comprised of thick trabeculae of woven bone with surrounding fascicles of minimally atypical spindled cells without mitotic activity. The tumor infiltrated the underlying cortex and was otherwise surrounded by a pseudocapsule. The intramedullary tumors were hypo-cellular to moderately cellular, with uniform mildly atypical spindled cells arranged in intersecting fascicles with variable amounts of collagen. Mitotic activity was very low. Most bone formation was woven and trabecular. In nearly half the cases, neoplastic cartilage was present. Wide excision was performed in most cases, and a few cases had marginal resections with positive margins. No cases developed recurrences or metastases.
